Painreform is trading 5% up at $1.05, based on the provided live quote, with no reliable company-specific announcement dated August 21, 2026 identified to explain the move.
- Search results mainly surfaced older or unrelated material, including a January 15, 2026 corporate name-change announcement and historical PRF-110 updates.
- The broader biotech sector is down 2.47%, so sector weakness does not explain the gain.
- Major indices are only modestly higher, and the reason remains uncertain.